Lilly's (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF

Published on September 10, 2021

The FDA bestows a Breakthrough Therapy status on Lilly's (LLY) Jardiance for heart failure with preserved ejection fraction (HFpEF).

Continue reading on website
Other news

Decoding Mu Variant: The Next Big Threat in COVID-19 Cases?

September 10, 2021
Another variant of the coronavirus, Mu Variant, is up on the WHO-identified list. One study finds its potential to be highly resistant to the COVID-19...

Mastercard (MA) to Buy CipherTrace, to Expand in CryptoCurrency

September 10, 2021
Mastercard (MA) to acquire CipherTrace to filter illicit cryptocurrency transactions and enhance security.